Weiss Multi Strategy Advisers LLC boosted its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 0.1% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 11,063 shares of the healthcare conglomerate’s stock after buying an additional 7 shares during the period. Weiss Multi Strategy Advisers LLC’s holdings in UnitedHealth Group were worth $1,814,000 at the end of the most recent quarter.

Several other large investors have also recently modified their holdings of UNH. Patriot Financial Group Insurance Agency LLC raised its position in UnitedHealth Group by 1,722.9% in the first quarter. Patriot Financial Group Insurance Agency LLC now owns 638 shares of the healthcare conglomerate’s stock valued at $106,000 after buying an additional 603 shares in the last quarter. Cribstone Capital Management LLC raised its position in UnitedHealth Group by 22.6% in the first quarter. Cribstone Capital Management LLC now owns 678 shares of the healthcare conglomerate’s stock valued at $113,000 after buying an additional 125 shares in the last quarter. Kings Point Capital Management raised its position in UnitedHealth Group by 27.9% in the first quarter. Kings Point Capital Management now owns 687 shares of the healthcare conglomerate’s stock valued at $113,000 after buying an additional 150 shares in the last quarter. Founders Capital Management bought a new position in UnitedHealth Group during the first quarter valued at $135,000. Finally, Parkside Financial Bank & Trust raised its position in UnitedHealth Group by 1.4% in the first quarter. Parkside Financial Bank & Trust now owns 854 shares of the healthcare conglomerate’s stock valued at $140,000 after buying an additional 12 shares in the last quarter. Institutional investors and hedge funds own 86.37% of the company’s stock.

UnitedHealth Group Incorporated (NYSE:UNH) traded up 0.33% during trading on Friday, hitting $193.20. 748,274 shares of the stock were exchanged. The firm has a 50-day moving average of $189.18 and a 200-day moving average of $174.51. The stock has a market capitalization of $186.80 billion, a price-to-earnings ratio of 23.21 and a beta of 0.64. UnitedHealth Group Incorporated has a 52 week low of $132.39 and a 52 week high of $196.04.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, July 18th. The healthcare conglomerate reported $2.46 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $2.38 by $0.08. The company had revenue of $50.05 billion during the quarter, compared to analysts’ expectations of $49.97 billion. UnitedHealth Group had a net margin of 4.32% and a return on equity of 21.52%. UnitedHealth Group’s quarterly revenue was up 7.7% on a year-over-year basis. During the same quarter in the previous year, the business posted $1.96 earnings per share. Equities research analysts anticipate that UnitedHealth Group Incorporated will post $9.87 earnings per share for the current fiscal year.

COPYRIGHT VIOLATION NOTICE: “UnitedHealth Group Incorporated (UNH) Shares Bought by Weiss Multi Strategy Advisers LLC” was originally reported by Daily Political and is the sole property of of Daily Political. If you are reading this news story on another publication, it was stolen and reposted in violation of United States & international copyright laws. The original version of this news story can be accessed at https://www.dailypolitical.com/2017/08/11/unitedhealth-group-incorporated-unh-shares-bought-by-weiss-multi-strategy-advisers-llc.html.

UNH has been the topic of several research reports. UBS AG reiterated a “buy” rating and issued a $194.00 price objective (up previously from $193.00) on shares of UnitedHealth Group in a research note on Saturday, April 22nd. Jefferies Group LLC reiterated a “buy” rating and issued a $192.00 price objective (up previously from $186.00) on shares of UnitedHealth Group in a research note on Saturday, April 22nd. Deutsche Bank AG reiterated a “buy” rating and issued a $187.00 price objective (up previously from $183.00) on shares of UnitedHealth Group in a research note on Saturday, April 22nd. Vetr upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $179.00 price objective on the stock in a research note on Monday, May 15th. Finally, Stifel Nicolaus reiterated a “buy” rating and issued a $185.00 price objective on shares of UnitedHealth Group in a research note on Wednesday, April 19th. One research analyst has rated the stock with a hold rating and twenty-four have given a buy rating to the stock. The company has an average rating of “Buy” and an average target price of $200.24.

In other news, Director William C. Ballard, Jr. sold 5,000 shares of the business’s stock in a transaction dated Thursday, August 3rd. The shares were sold at an average price of $193.98, for a total value of $969,900.00. Following the completion of the sale, the director now owns 76,058 shares of the company’s stock, valued at $14,753,730.84. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Gail R. Wilensky sold 5,540 shares of the business’s stock in a transaction dated Friday, June 2nd. The shares were sold at an average price of $178.74, for a total transaction of $990,219.60. Following the completion of the sale, the director now directly owns 60,516 shares of the company’s stock, valued at approximately $10,816,629.84. The disclosure for this sale can be found here. In the last three months, insiders sold 15,540 shares of company stock valued at $2,873,320. 0.89% of the stock is currently owned by company insiders.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.